Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway

Title
Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway
Authors
Keywords
Tongmai Yangxin pill, Coronary heart disease, Anti-inflammatory activity, Estrogen receptor 1, NF-κB
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 276, Issue -, Pages 114106
Publisher
Elsevier BV
Online
2021-04-07
DOI
10.1016/j.jep.2021.114106

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started